Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Completed 230 Recruiting 73 Unknown 65 Active not recruiting 45 Terminated 42 Not yet recruiting 17 Withdrawn 4 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Paclitaxel 3 Surgical Procedures, Operative 2 Radiotherapy 2 Oxaliplatin 2 Magnetic Resonance Spectroscopy 2 Fluorouracil 2 Doxorubicin 2 Cyclophosphamide 2 titanium silicide 1 sargramostim 1 exemestane 1 eribulin 1 cemiplimab 1 Vincristine 1 Taxes 1 Tamoxifen 1 Surveys and Questionnaires 1 Specimen Handling 1 S 1 (combination) 1 Rituximab 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Prednisone 1 Prednisolone 1 Passive Cutaneous Anaphylaxis 1 Neoadjuvant Therapy 1 Morphine 1 Methylprednisolone 1 Methotrexate 1 Methods 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Suspended × Docetaxel × Clear all

NCT05378763 2026-05-22

PINNACLE

Spectrum Pharmaceuticals, Inc

Phase 3 Suspended

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡